Zdrowie i gospodarka · 23/01/2020
FDA Announces Revised Draft Guidance for Levonorgestrel Intrauterine Device
The FDA is releasing a revised draft guidance for industry, which will provide product-specific recommendations for a levonorgestrel intrauterine device, including design requirements for bioequivalence studies to support abbreviated new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →